1 / 5

Nanomedicines

Nanotechnology is a common term for nanoscale science, engineering and technology, which offers extraordinary economic and technological benefits. Healthcare is one of the most prominent field of research in nanotechnology. Nanomedicine can be understood as a field of diagnosing, treating and preventing disease using molecular tools and knowledge of the human body.

Pooja76
Download Presentation

Nanomedicines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nanomedicines Market

  2. The global nanomedicine market was valued at US$ 177.1 Bn in 2019 and is forecast to reach a value of US$ 454.8 Bn by 2027 at a CAGR of 12.5% between 2020 and 2027. • Nanotechnology is a broad term for nanoscale science, engineering, and technology that has enormous economic and technological implications. • One of the most prominent areas of nanotechnology research is healthcare. • Nanomedicine is defined as the use of molecular tools and knowledge of the human body to diagnose, treat, and prevent disease.

  3. Growth drivers- • Increasing prevalence of chronic diseases • Approval and launch of new products • Top companies involved are- Abbott Laboratories, CombiMatrix Corporation, Clene Nanomedicine, Inc., Cellics Therapeutics, Inc., Nanobiotix S.A, Celgene Corporation, GE Healthcare, NanoViricides, Inc., Johnson & Johnson, Mallinckrodt plc., Sirnaomics Inc., Precision NanoSystems Inc., Merck & Company Inc., Nanosphere, Inc., Pfizer Inc., and Sigma-Tau Pharmaceuticals Inc.

  4. Growth opportunities • The presence of unmet medical needs in emerging economies is expected to provide lucrative growth opportunities for global nanomedicine market participants. • Emerging and high-growth markets such as China, Brazil, India, Eastern Europe, the Middle East, and Latin America are expected to provide a plethora of opportunities in the future for the nanomedicine market. • This is because economic development in these economies has provided patients with increased purchasing power as a result of rising disposable incomes. • Improvements to healthcare infrastructure will allow for the use of sophisticated technologies while also meeting the population's high unmet medical needs. • For more details visit- https://coherentmarketinsightsus.blogspot.com/2022/08/nanomedicines-is-use-of-nanotechnology.html

  5. Thank you • Contact us- • Sales Office (U.S.) : Coherent Market Insights Pvt Ltd, 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Email- sales@coherentmarketinsights.com Phone- +1-206-701-6702

More Related